CRA INTERNATIONAL INC (CRAI)

US12618T1051 - Common Stock

149.71  +2.69 (+1.83%)

After market: 149.71 0 (0%)

Fundamental Rating

6

Overall CRAI gets a fundamental rating of 6 out of 10. We evaluated CRAI against 81 industry peers in the Professional Services industry. CRAI has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. CRAI is quite expensive at the moment. It does show a decent growth rate.



7

1. Profitability

1.1 Basic Checks

In the past year CRAI was profitable.
CRAI had a positive operating cash flow in the past year.
CRAI had positive earnings in each of the past 5 years.
In the past 5 years CRAI always reported a positive cash flow from operatings.

1.2 Ratios

CRAI's Return On Assets of 6.95% is fine compared to the rest of the industry. CRAI outperforms 75.00% of its industry peers.
CRAI has a Return On Equity of 18.11%. This is in the better half of the industry: CRAI outperforms 76.25% of its industry peers.
CRAI has a better Return On Invested Capital (13.40%) than 75.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CRAI is in line with the industry average of 12.23%.
The 3 year average ROIC (12.81%) for CRAI is below the current ROIC(13.40%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 6.95%
ROE 18.11%
ROIC 13.4%
ROA(3y)7.43%
ROA(5y)6.11%
ROE(3y)19.61%
ROE(5y)16.2%
ROIC(3y)12.81%
ROIC(5y)10.31%

1.3 Margins

CRAI has a Profit Margin of 6.16%. This is in the better half of the industry: CRAI outperforms 73.75% of its industry peers.
In the last couple of years the Profit Margin of CRAI has grown nicely.
CRAI has a better Operating Margin (9.22%) than 67.50% of its industry peers.
CRAI's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 29.52%, CRAI is doing worse than 63.75% of the companies in the same industry.
CRAI's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 9.22%
PM (TTM) 6.16%
GM 29.52%
OM growth 3Y10.45%
OM growth 5Y5.91%
PM growth 3Y8.59%
PM growth 5Y2.76%
GM growth 3Y2.92%
GM growth 5Y-0.82%

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CRAI is still creating some value.
CRAI has less shares outstanding than it did 1 year ago.
CRAI has less shares outstanding than it did 5 years ago.
CRAI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

An Altman-Z score of 3.90 indicates that CRAI is not in any danger for bankruptcy at the moment.
CRAI has a Altman-Z score of 3.90. This is in the better half of the industry: CRAI outperforms 75.00% of its industry peers.
There is no outstanding debt for CRAI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 3.9
ROIC/WACC1.44
WACC9.34%

2.3 Liquidity

CRAI has a Current Ratio of 1.12. This is a normal value and indicates that CRAI is financially healthy and should not expect problems in meeting its short term obligations.
CRAI has a Current ratio (1.12) which is in line with its industry peers.
A Quick Ratio of 1.12 indicates that CRAI should not have too much problems paying its short term obligations.
CRAI's Quick ratio of 1.12 is in line compared to the rest of the industry. CRAI outperforms 42.50% of its industry peers.
Industry RankSector Rank
Current Ratio 1.12
Quick Ratio 1.12

4

3. Growth

3.1 Past

The earnings per share for CRAI have decreased by -7.58% in the last year.
Measured over the past years, CRAI shows a quite strong growth in Earnings Per Share. The EPS has been growing by 13.69% on average per year.
The Revenue has been growing slightly by 5.60% in the past year.
The Revenue has been growing by 8.36% on average over the past years. This is quite good.
EPS 1Y (TTM)-7.58%
EPS 3Y17.9%
EPS 5Y13.69%
EPS growth Q2Q36.97%
Revenue 1Y (TTM)5.6%
Revenue growth 3Y7.07%
Revenue growth 5Y8.36%
Revenue growth Q2Q11.46%

3.2 Future

The Earnings Per Share is expected to grow by 11.43% on average over the next years. This is quite good.
Based on estimates for the next years, CRAI will show a small growth in Revenue. The Revenue will grow by 6.14% on average per year.
EPS Next Y10.24%
EPS Next 2Y11.43%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year7.22%
Revenue Next 2Y6.14%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 27.27, which means the current valuation is very expensive for CRAI.
Compared to the rest of the industry, the Price/Earnings ratio of CRAI is on the same level as its industry peers.
Compared to an average S&P500 Price/Earnings ratio of 24.84, CRAI is valued at the same level.
The Price/Forward Earnings ratio is 24.74, which indicates a rather expensive current valuation of CRAI.
CRAI's Price/Forward Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.35, CRAI is valued at the same level.
Industry RankSector Rank
PE 27.27
Fwd PE 24.74

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as CRAI.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CRAI indicates a somewhat cheap valuation: CRAI is cheaper than 70.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 18.06
EV/EBITDA 14.15

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The decent profitability rating of CRAI may justify a higher PE ratio.
PEG (NY)2.66
PEG (5Y)1.99
EPS Next 2Y11.43%
EPS Next 3YN/A

4

5. Dividend

5.1 Amount

CRAI has a Yearly Dividend Yield of 1.14%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 2.07, CRAI pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.41, CRAI's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.14%

5.2 History

CRAI has been paying a dividend for over 5 years, so it has already some track record.
As CRAI did not decrease their dividend in the past 5 years, we can say the dividend looks stable.
Dividend Growth(5Y)N/A
Div Incr Years7
Div Non Decr Years7

5.3 Sustainability

CRAI pays out 28.13% of its income as dividend. This is a sustainable payout ratio.
DP28.13%
EPS Next 2Y11.43%
EPS Next 3YN/A

CRA INTERNATIONAL INC

NASDAQ:CRAI (4/26/2024, 7:00:00 PM)

After market: 149.71 0 (0%)

149.71

+2.69 (+1.83%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap1.04B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 1.14%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 27.27
Fwd PE 24.74
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)2.66
PEG (5Y)1.99
Profitability
Industry RankSector Rank
ROA 6.95%
ROE 18.11%
ROCE
ROIC
ROICexc
ROICexgc
OM 9.22%
PM (TTM) 6.16%
GM 29.52%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.13
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.12
Quick Ratio 1.12
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-7.58%
EPS 3Y17.9%
EPS 5Y
EPS growth Q2Q
EPS Next Y10.24%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)5.6%
Revenue growth 3Y7.07%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y